Circassia Pharmaceuticals (CIR) Health Care Sector

  • Latest quote

    29.70p (mid)

  • Current Change (%)

    -0.67%

  • Price

    Bid: 29.50p

    Offer: 29.90p

  • Today

    High: 30.00p

    Low: 29.20p

  • This year

    High: 97.90p

    Low: 28.00p

  • Information

    Volume: 29,600

    Market Cap: £111.08M



Circassia Pharmaceuticals Overview

Circassia is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

Circassia Pharmaceuticals RNS Feed

Title Release date
Holding(s) in Company 11:55 - April 15, 2019
FDA approval of Duaklir for treatment of COPD 07:00 - April 1, 2019
Second Price Monitoring Extn 16:40 - March 29, 2019
Price Monitoring Extension 16:35 - March 29, 2019
FDA website posts Duaklir NDA approval 15:58 - March 29, 2019
Circassia announces FDA approval of Tudorza sNDA 15:34 - March 29, 2019
Total Voting Rights 07:00 - March 29, 2019
Holding(s) in Company 16:53 - March 5, 2019
Total Voting Rights 07:00 - February 28, 2019
Holding(s) in Company 17:17 - February 11, 2019
Notice of Results 09:00 - February 8, 2019
Holding(s) in Company 16:44 - February 6, 2019
Holding(s) in Company 07:00 - February 6, 2019
Holding(s) in Company 17:57 - February 4, 2019
Admission to AIM 08:06 - February 4, 2019

NOTE: This is based on 18 open tips for this company


Total Number of Share tips :

43

View all Circassia Pharmaceuticals Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today